NEUBASE THERAPEUTICS INC - COM (NBSE)

CUSIP: 64132K102

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM
Total 13F shares
46,970
Share change
-50,100
Total reported value
$40,855
Price per share
$0.87
Number of holders
1
Value change
-$92,515
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 64132K102?
CUSIP 64132K102 identifies NBSE - NEUBASE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUBASE THERAPEUTICS INC - COM (NBSE) as of Q3 2023

As of 30 Sep 2023, NEUBASE THERAPEUTICS INC - COM (NBSE) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 46,970 shares. The largest 1 holders included CARNEGIE MELLON UNIVERSITY. This page lists 1 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.